Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1978 Aug;21(2):425–429. doi: 10.1128/iai.21.2.425-429.1978

Cell-Mediated Immunity in Diabetes Mellitus

Joseph F Plouffe 1,, Joseph Silva Jr 1, Robert Fekety 1, Jamie L Allen 1
PMCID: PMC422013  PMID: 308493

Abstract

Cell-mediated immunity was evaluated in patients with diabetes mellitus by delayed hypersensitivity skin tests and in vitro lymphocyte transformations. Only 44% of diabetic patients had skin test reactivity to Candida antigen, compared with 88% of normal controls (P < 0.001). Insulin-dependent diabetic (IDD) patients had abnormally low lymphocyte transformation responses to phytohemagglutinin, concanavalin A, and streptokinase-streptodornase (P < 0.05). This defect was not corrected by culturing the cells in nondiabetic plasma. IDD patients with persistent hyperglycemia (fasting serum glucose level, >200 mg/dl) had lower levels of transformation than did IDD patients with fasting serum glucose levels less than 150 mg/dl. Lymphocytes from two IDD patients with poor lymphocyte transformation responses had marked improvement in response to phytohemagglutinin when the lymphocytes were cultured after a preincubation period designed to deplete cultures of suppressor activity. Seven IDD patients were studied serially over 12 months. Lymphocyte transformation responses in four of these patients improved coincidentally with a change in the level of fasting hyperglycemia from >200 to <150 mg/dl. The other three IDD patients with consistent fasting serum glucose levels of >200 mg/dl had poor lymphocyte transformation responses. Diabetic patients have demonstrable defects in lymphocyte function which improved in a small number of patients with reduction in the level of fasting hyperglycemia.

Full text

PDF
428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer J. A., Gorden P., Roth J. Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. J Clin Invest. 1975 Jan;55(1):166–174. doi: 10.1172/JCI107907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BYBEE J. D., ROGERS D. E. THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS. J Lab Clin Med. 1964 Jul;64:1–13. [PubMed] [Google Scholar]
  3. Bagdade J. D., Root R. K., Bulger R. J. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974 Jan;23(1):9–15. doi: 10.2337/diab.23.1.9. [DOI] [PubMed] [Google Scholar]
  4. Brody J. I., Merlie K. Metabolic and biosynthetic features of lymphocytes from patients with diabetes mellitus: similarities to lymphocytes in chronic lymphocytic leukaemia. Br J Haematol. 1970 Aug;19(2):193–201. doi: 10.1111/j.1365-2141.1970.tb01616.x. [DOI] [PubMed] [Google Scholar]
  5. Delespesse G., Duchateau J., Bastenie P. A., Lauvaux J. P., Collet H., Govaerts A. Cell-mediated immunity in diabetes mellitus. Clin Exp Immunol. 1974 Dec;18(4):461–467. [PMC free article] [PubMed] [Google Scholar]
  6. GOODMAN H. L., NELSON N. A., OSTER H. L. The association of histoplasmosis and lymphoma. Am J Med Sci. 1957 Jan;233(1):56–65. doi: 10.1097/00000441-195701000-00010. [DOI] [PubMed] [Google Scholar]
  7. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  8. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  9. LIPSCOMB H., DOBSON H. L., GREENE J. A. Infection in the diabetic. South Med J. 1959 Jan;52(1):16–23. doi: 10.1097/00007611-195901000-00003. [DOI] [PubMed] [Google Scholar]
  10. MacCuish A. C., Urbaniak S. J., Campbell C. J., Duncan L. J., Irvine W. J. Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes. 1974 Aug;23(8):708–712. doi: 10.2337/diab.23.8.708. [DOI] [PubMed] [Google Scholar]
  11. Mangi R. J., Dwyer J. M., Kantor F. S. The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol. 1974 Dec;18(4):519–528. [PMC free article] [PubMed] [Google Scholar]
  12. Mowat A., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971 Mar 25;284(12):621–627. doi: 10.1056/NEJM197103252841201. [DOI] [PubMed] [Google Scholar]
  13. Newberry W. M., Sanford J. P. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest. 1971 Jun;50(6):1262–1271. doi: 10.1172/JCI106604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Newberry W. M., Shorey J. W., Sanford J. P., Combes B. Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell Immunol. 1973 Jan;6(1):87–97. doi: 10.1016/0008-8749(73)90009-9. [DOI] [PubMed] [Google Scholar]
  15. PERILLIE P. E., NOLAN J. P., FINCH S. C. Studies of the resistance to infection in diabetes mellitus: local exudative cellular response. J Lab Clin Med. 1962 Jun;59:1008–1015. [PubMed] [Google Scholar]
  16. Ragab A. H., Hazlett B., Cowan D. H. Response of peripheral blood lymphocytes from patients with diabetes mellitus to phytohemagglutinin and Candida albicans antigen. Diabetes. 1972 Aug;21(8):906–907. doi: 10.2337/diab.21.8.906. [DOI] [PubMed] [Google Scholar]
  17. Rosen F. S. The lymphocyte and the thymus gland--congenital and hereditary abnormalities. N Engl J Med. 1968 Sep 19;279(12):643–648. doi: 10.1056/NEJM196809192791207. [DOI] [PubMed] [Google Scholar]
  18. Stobo J. D., Paul S., Van Scoy R. E., Hermans P. E. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest. 1976 Feb;57(2):319–328. doi: 10.1172/JCI108283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thornton G. F. Infections and diabetes. Med Clin North Am. 1971 Jul;55(4):931–938. doi: 10.1016/s0025-7125(16)32487-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES